Xolair 300 MG/2 ML autoinject 2ML
Ended Awarded
- Contract number
- SPE2DB25FDRBP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,547
Award facts
- Contract value 100% obligated
- $20,546.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $20,546.76 by the Defense Logistics Agency (DLA) on September 16, 2025. The contract calls for the delivery of Xolair 300 mg/2 ml auto-injector vials, a biologic medication used to treat moderate-to-severe allergic asthma and chronic idiopathic urticaria. The award utilizes no set-aside designation and has an ultimate completion date of October 7, 2025, with performance taking place at the vendor's Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC framework enables the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively while providing direct distribution of prescription drugs and specialty medications to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FDRBP?
SPE2DB25FDRBP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FDRBP worth?
The government has obligated $20,547 on SPE2DB25FDRBP.
Is contract SPE2DB25FDRBP an order under another contract?
Yes. SPE2DB25FDRBP is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDRBP competed?
The extent of competition for SPE2DB25FDRBP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award